GANX Annual Long Term Debt
$678.90 K
-$258.10 K-27.55%
31 December 2023
Summary:
As of January 23, 2025, GANX annual long term debt is $678.90 thousand, with the most recent change of -$258.10 thousand (-27.55%) on December 31, 2023. During the last 3 years, it has fallen by -$437.10 thousand (-39.17%). GANX annual long term debt is now -47.19% below its all-time high of $1.29 million, reached on December 31, 2021.GANX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GANX Quarterly Long Term Debt
$472.40 K
-$37.30 K-7.32%
30 September 2024
Summary:
As of January 23, 2025, GANX quarterly long term debt is $472.40 thousand, with the most recent change of -$37.30 thousand (-7.32%) on September 30, 2024. Over the past year, it has dropped by -$206.50 thousand (-30.42%). GANX quarterly long term debt is now -63.25% below its all-time high of $1.29 million, reached on December 1, 2021.GANX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GANX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.6% | -30.4% |
| 3 y3 years | -39.2% | -63.3% |
| 5 y5 years | - | -63.3% |
GANX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.2% | at low | -63.3% | at low |
| 5 y | 5-year | -47.2% | +587.1% | -63.3% | at low |
| alltime | all time | -47.2% | +587.1% | -63.3% | at low |
Gain Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $472.40 K(-7.3%) |
| June 2024 | - | $509.70 K(-11.2%) |
| Mar 2024 | - | $574.20 K(-15.4%) |
| Dec 2023 | $678.90 K(-27.5%) | $678.90 K(-2.8%) |
| Sept 2023 | - | $698.40 K(-12.3%) |
| June 2023 | - | $796.70 K(-7.8%) |
| Mar 2023 | - | $864.20 K(-7.8%) |
| Dec 2022 | $937.00 K | $937.00 K(-1.7%) |
| Sept 2022 | - | $952.80 K(-12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $1.09 M(-8.4%) |
| Mar 2022 | - | $1.19 M(-7.7%) |
| Dec 2021 | $1.29 M(+15.2%) | - |
| Dec 2021 | - | $1.29 M(+7.4%) |
| Sept 2021 | - | $1.20 M(-6.3%) |
| June 2021 | - | $1.28 M(+21.0%) |
| Mar 2021 | - | $1.06 M(-5.4%) |
| Dec 2020 | $1.12 M(+1029.6%) | - |
| Dec 2020 | - | $1.12 M |
| Dec 2019 | $98.80 K | - |
FAQ
- What is Gain Therapeutics annual long term debt?
- What is the all time high annual long term debt for Gain Therapeutics?
- What is Gain Therapeutics annual long term debt year-on-year change?
- What is Gain Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Gain Therapeutics?
- What is Gain Therapeutics quarterly long term debt year-on-year change?
What is Gain Therapeutics annual long term debt?
The current annual long term debt of GANX is $678.90 K
What is the all time high annual long term debt for Gain Therapeutics?
Gain Therapeutics all-time high annual long term debt is $1.29 M
What is Gain Therapeutics annual long term debt year-on-year change?
Over the past year, GANX annual long term debt has changed by -$258.10 K (-27.55%)
What is Gain Therapeutics quarterly long term debt?
The current quarterly long term debt of GANX is $472.40 K
What is the all time high quarterly long term debt for Gain Therapeutics?
Gain Therapeutics all-time high quarterly long term debt is $1.29 M
What is Gain Therapeutics quarterly long term debt year-on-year change?
Over the past year, GANX quarterly long term debt has changed by -$206.50 K (-30.42%)